Furthermore, our analysis uncovered a high expression of PTGS2 (Prostaglandin-Endoperoxide Synthase 2), with a fivefold or greater increase observed in 68% of the tumor samples (Table 6). The gene discussed is PTGS2; the disease is neoplasm.